Sarah Pitluck

Sarah Pitluck

Company: Spark Therapeutics

Job title: Former Vice President & Head Of Global Pricing & Reimbursement Strategy


Ms. Pitluck has focused the past 20 years of her career on global healthcare access issues including pricing and reimbursement (P&R) strategy, public policy, market access, and patient advocacy for new biotechnology products. Most recently, she was VP and Head of Global P&R at Spark Therapeutics where she priced the first FDA-approved gene therapy for a genetic disease, LUXTURNA®, and led the roll-out of Spark’s unique alternate payment options and outcomes-based arrangements.

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.